ibrutinib,zanubrutinib
abbvie,beigene,janssen
['zanubrutinib', 'cll', ' ibru', 'alpine']
following alpine at #ash22? in a head-to-head comparison, zanubrutinib achieved superiority in both orr and pfs, as well as a more favorable safety profile over ibrutinib in pts with r/r cll/sll across all major subgroups. #noeticinsight 